Literature DB >> 15793292

Distal myopathy with rimmed vacuoles: impaired O-glycan formation in muscular glycoproteins.

Youichi Tajima1, Eiichiro Uyama, Shinji Go, Chihiro Sato, Nodoka Tao, Masaharu Kotani, Hirotake Hino, Akemi Suzuki, Yutaka Sanai, Ken Kitajima, Hitoshi Sakuraba.   

Abstract

Distal myopathy with rimmed vacuoles (DMRV), is an autosomal recessive disorder with early adult onset, displays distal dominant muscular involvement and is characterized by the presence of numerous rimmed vacuoles in the affected muscle fibers. The pathophysiology of DMRV has not been clarified yet, although the responsible gene was identified as that encoding UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase involved in the biosynthesis of sialic acids. To identify defective carbohydrate moieties of muscular glycoproteins from DMRV patients, frozen skeletal muscle sections from seven patients with DMRV, as well as normal and pathological controls, were treated with or without sialidase or N-glycosidase F followed by lectin staining and lectin blotting analysis. The sialic acid contents of the O-glycans in the skeletal muscle specimens from the DMRV patients were also measured. We found that Arachis hypogaea agglutinin (PNA) lectin reacted strongly with sarcolemmal glycoproteins in the DMRV patients but not with those in control subjects. alpha-Dystroglycan from the DMRV patients strongly associated with PNA lectin, although that from controls did not. The sialic acid level of the O-glycans in the DMRV muscular glycoproteins with molecular weights of 30 to 200 kd was reduced to 60 to 80% of the control level. The results show that impaired sialyl O-glycan formation in muscular glycoproteins, including alpha-dystroglycan, occurs in DMRV.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15793292      PMCID: PMC1602383          DOI: 10.1016/S0002-9440(10)62332-2

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  34 in total

1.  Physical and transcriptional map of the hereditary inclusion body myopathy locus on chromosome 9p12-p13.

Authors:  I Eisenberg; H Hochner; M Shemesh; T Levi; T Potikha; M Sadeh; Z Argov; C L Jackson; S Mitrani-Rosenbaum
Journal:  Eur J Hum Genet       Date:  2001-07       Impact factor: 4.246

2.  UDP-GlcNAc 2-epimerase: a regulator of cell surface sialylation.

Authors:  O T Keppler; S Hinderlich; J Langner; R Schwartz-Albiez; W Reutter; M Pawlita
Journal:  Science       Date:  1999-05-21       Impact factor: 47.728

Review 3.  Genetics of inclusion body myopathies.

Authors:  Z Argov; I Eisenberg; S Mitrani-Rosenbaum
Journal:  Curr Opin Rheumatol       Date:  1998-11       Impact factor: 5.006

4.  Gene locus for autosomal recessive distal myopathy with rimmed vacuoles maps to chromosome 9.

Authors:  T Ikeuchi; T Asaka; M Saito; H Tanaka; S Higuchi; K Tanaka; K Saida; E Uyama; H Mizusawa; N Fukuhara; I Nonaka; M Takamori; S Tsuji
Journal:  Ann Neurol       Date:  1997-04       Impact factor: 10.422

5.  A bifunctional enzyme catalyzes the first two steps in N-acetylneuraminic acid biosynthesis of rat liver. Molecular cloning and functional expression of UDP-N-acetyl-glucosamine 2-epimerase/N-acetylmannosamine kinase.

Authors:  R Stäsche; S Hinderlich; C Weise; K Effertz; L Lucka; P Moormann; W Reutter
Journal:  J Biol Chem       Date:  1997-09-26       Impact factor: 5.157

6.  Frequent occurrence of pre-existing alpha 2-->8-linked disialic and oligosialic acids with chain lengths up to 7 Sia residues in mammalian brain glycoproteins. Prevalence revealed by highly sensitive chemical methods and anti-di-, oligo-, and poly-Sia antibodies specific for defined chain lengths.

Authors:  C Sato; H Fukuoka; K Ohta; T Matsuda; R Koshino; K Kobayashi; F A Troy; K Kitajima
Journal:  J Biol Chem       Date:  2000-05-19       Impact factor: 5.157

7.  Dissociation of the dystroglycan complex in caveolin-3-deficient limb girdle muscular dystrophy.

Authors:  R Herrmann; V Straub; M Blank; C Kutzick; N Franke; E N Jacob; H G Lenard; S Kröger; T Voit
Journal:  Hum Mol Genet       Date:  2000-09-22       Impact factor: 6.150

8.  Tissue-specific heterogeneity in alpha-dystroglycan sialoglycosylation. Skeletal muscle alpha-dystroglycan is a latent receptor for Vicia villosa agglutinin b4 masked by sialic acid modification.

Authors:  J M Ervasti; A L Burwell; A L Geissler
Journal:  J Biol Chem       Date:  1997-08-29       Impact factor: 5.157

9.  Detection of O-mannosyl glycans in rabbit skeletal muscle alpha-dystroglycan.

Authors:  T Sasaki; H Yamada; K Matsumura; T Shimizu; A Kobata; T Endo
Journal:  Biochim Biophys Acta       Date:  1998-11-27

10.  The sialomucin CD164 (MGC-24v) is an adhesive glycoprotein expressed by human hematopoietic progenitors and bone marrow stromal cells that serves as a potent negative regulator of hematopoiesis.

Authors:  A C Zannettino; H J Bühring; S Niutta; S M Watt; M A Benton; P J Simmons
Journal:  Blood       Date:  1998-10-15       Impact factor: 22.113

View more
  29 in total

1.  Clinical features, lectin staining, and a novel GNE frameshift mutation in hereditary inclusion body myopathy.

Authors:  N C Voermans; M Guillard; R Doedée; M Lammens; M Huizing; G W Padberg; R A Wevers; B G van Engelen; D J Lefeber
Journal:  Clin Neuropathol       Date:  2010 Mar-Apr       Impact factor: 1.368

2.  Application of WGA lectin staining for visualization of the connective tissue in skeletal muscle, bone, and ligament/tendon studies.

Authors:  Tatiana Y Kostrominova
Journal:  Microsc Res Tech       Date:  2011-01       Impact factor: 2.769

3.  Mutations in GFPT1-related congenital myasthenic syndromes are associated with synaptic morphological defects and underlie a tubular aggregate myopathy with synaptopathy.

Authors:  Stéphanie Bauché; Geoffroy Vellieux; Damien Sternberg; Marie-Joséphine Fontenille; Elodie De Bruyckere; Claire-Sophie Davoine; Guy Brochier; Julien Messéant; Lucie Wolf; Michel Fardeau; Emmanuelle Lacène; Norma Romero; Jeanine Koenig; Emmanuel Fournier; Daniel Hantaï; Nathalie Streichenberger; Veronique Manel; Arnaud Lacour; Aleksandra Nadaj-Pakleza; Sylvie Sukno; Françoise Bouhour; Pascal Laforêt; Bertrand Fontaine; Laure Strochlic; Bruno Eymard; Frédéric Chevessier; Tanya Stojkovic; Sophie Nicole
Journal:  J Neurol       Date:  2017-07-15       Impact factor: 4.849

4.  Sialylation of Thomsen-Friedenreich antigen is a noninvasive blood-based biomarker for GNE myopathy.

Authors:  Petcharat Leoyklang; May Christine Malicdan; Tal Yardeni; Frank Celeste; Carla Ciccone; Xueli Li; Rong Jiang; William A Gahl; Nuria Carrillo-Carrasco; Miao He; Marjan Huizing
Journal:  Biomark Med       Date:  2014       Impact factor: 2.851

Review 5.  Mutation update for GNE gene variants associated with GNE myopathy.

Authors:  Frank V Celeste; Thierry Vilboux; Carla Ciccone; John Karl de Dios; May Christine V Malicdan; Petcharat Leoyklang; John C McKew; William A Gahl; Nuria Carrillo-Carrasco; Marjan Huizing
Journal:  Hum Mutat       Date:  2014-08       Impact factor: 4.878

6.  Genetics of GNE myopathy in the non-Jewish Persian population.

Authors:  Alireza Haghighi; Shahriar Nafissi; Abrar Qurashi; Zheng Tan; Hosein Shamshiri; Yalda Nilipour; Amirreza Haghighi; Robert J Desnick; Ruth Kornreich
Journal:  Eur J Hum Genet       Date:  2015-05-13       Impact factor: 4.246

7.  Peracetylated N-acetylmannosamine, a synthetic sugar molecule, efficiently rescues muscle phenotype and biochemical defects in mouse model of sialic acid-deficient myopathy.

Authors:  May Christine V Malicdan; Satoru Noguchi; Tomoharu Tokutomi; Yu-ichi Goto; Ikuya Nonaka; Yukiko K Hayashi; Ichizo Nishino
Journal:  J Biol Chem       Date:  2011-12-08       Impact factor: 5.157

8.  Deficiency of Dol-P-Man synthase subunit DPM3 bridges the congenital disorders of glycosylation with the dystroglycanopathies.

Authors:  Dirk J Lefeber; Johannes Schönberger; Eva Morava; Mailys Guillard; Karin M Huyben; Kiek Verrijp; Olga Grafakou; Athanasios Evangeliou; Frank W Preijers; Panagiota Manta; Jef Yildiz; Stephanie Grünewald; Martha Spilioti; Christa van den Elzen; Dominique Klein; Daniel Hess; Hisashi Ashida; Jan Hofsteenge; Yusuke Maeda; Lambert van den Heuvel; Martin Lammens; Ludwig Lehle; Ron A Wevers
Journal:  Am J Hum Genet       Date:  2009-07-02       Impact factor: 11.025

9.  Tissue specific expression of sialic acid metabolic pathway: role in GNE myopathy.

Authors:  Kapila Awasthi; Alok Srivastava; Sudha Bhattacharya; Alok Bhattacharya
Journal:  J Muscle Res Cell Motil       Date:  2020-10-07       Impact factor: 2.698

10.  Hereditary Inclusion Body Myopathy (HIBM2).

Authors:  Chris M Jay; Nick Levonyak; Gregory Nemunaitis; Phillip B Maples; John Nemunaitis
Journal:  Gene Regul Syst Bio       Date:  2009-10-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.